newsfilter
← Latest News
GlobeNewswire·

Galecto Announces Acquisition of Damora Therapeutics

Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproliferative Neoplasms